Open-source ecosystem for in vitro and microphysiological systems
Menu

About

AboutGovernanceResponsible DataSecurity & PrivacyPolicies

Data

Data LibraryFind Data

Contribute

On-RampSubmit DataContributor MetadataDashboard

Tools

ToolsOpen SourceDevelopersSandboxGitHub

Learning & Community

Learning NetworkResourcesNews and EventsCommunityFor IndustryContact
Save the DateDecember 1-2, 2026Charlotte, North Carolina12th Annual Regenerative Manufacturing Innovation Consortium (RegMIC) Meeting: A Roadmap for Tissue Organoids and Body-on-a-Chip Manufacturing Standards
About MOSSDOAbout RegMICAbout the RegMIC 2026 meeting
Back to Home

For Industry

Industry, Translation, and Commercialization Pathways

PhysioVerse provides entry points for industry partners interested in advanced model systems, quality practices, standards exchange, facilities, and translational adoption.

Industry pathways

Practical ways to connect with the open ecosystem

This page outlines the first set of industry-facing pathways. Additional program details, opportunities, and partner resources will be added as activities are finalized.

Consortium participation

Collaboration pathways for companies, institutions, and translational partners interested in shared infrastructure and working groups.

Coming soon

Facilities and services

Connections to testbeds, platform capabilities, service models, and translational resources as partner programs mature.

Coming soon

Commercialization and IP

Guidance areas for moving validated technologies toward adoption, commercialization, and responsible use.

Coming soon

Standards and quality

Alignment around benchmarking, validity testing, quality practices, metadata, and implementation readiness.

Coming soon

Partner with PhysioVerse

Discuss translational needs, data resources, standards, or tool development

Contact the team to explore how your organization can participate.

Contact the TeamStandards Exchange

Standards and manufacturing partners

MOSSDO and RegMIC

Connect with the organizations advancing consensus standards, validation, and regenerative manufacturing across the PhysioVerse ecosystem.

About MOSSDO

The Microphysiological and Organoid Systems Standards Development Organization (MOSSDO) is a federally funded multi-stakeholder initiative focused specifically on establishing consensus-based standards for organoids, microphysiological systems (MPS), and body-on-a-chip technologies. MOSSDO develops frameworks for reproducibility, validation, and interoperability, enabling these platforms to be more reliably adopted across research, regulatory, and translational settings. In coordination with enabling ecosystem efforts such as PhysioVerse, MOSSDO provides the standards foundation that supports data integration, comparability, and broader field-wide adoption.

About RegMIC

The Regenerative Manufacturing Innovation Consortium (RegMIC), founded in 2014, is a national initiative that brings together stakeholders from industry, academia, and government to advance the manufacturing, scale-up, and commercialization of regenerative technologies. Through cross-sector collaboration, RegMIC addresses key challenges in translation, including process development, regulatory alignment, and the establishment of best practices across cell, tissue, and advanced in vitro systems.